1. Home
  2. RPRX vs SCI Comparison

RPRX vs SCI Comparison

Compare RPRX & SCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RPRX
  • SCI
  • Stock Information
  • Founded
  • RPRX 1996
  • SCI 1962
  • Country
  • RPRX United States
  • SCI United States
  • Employees
  • RPRX N/A
  • SCI N/A
  • Industry
  • RPRX Biotechnology: Pharmaceutical Preparations
  • SCI Other Consumer Services
  • Sector
  • RPRX Health Care
  • SCI Consumer Discretionary
  • Exchange
  • RPRX Nasdaq
  • SCI Nasdaq
  • Market Cap
  • RPRX 14.2B
  • SCI 11.3B
  • IPO Year
  • RPRX 2020
  • SCI N/A
  • Fundamental
  • Price
  • RPRX $33.10
  • SCI $75.50
  • Analyst Decision
  • RPRX Strong Buy
  • SCI Strong Buy
  • Analyst Count
  • RPRX 4
  • SCI 4
  • Target Price
  • RPRX $42.50
  • SCI $89.25
  • AVG Volume (30 Days)
  • RPRX 3.9M
  • SCI 1.4M
  • Earning Date
  • RPRX 05-08-2025
  • SCI 04-30-2025
  • Dividend Yield
  • RPRX 2.66%
  • SCI 1.70%
  • EPS Growth
  • RPRX 37.42
  • SCI 3.75
  • EPS
  • RPRX 2.45
  • SCI 3.62
  • Revenue
  • RPRX $2,263,576,000.00
  • SCI $4,215,163,999.00
  • Revenue This Year
  • RPRX $31.30
  • SCI $3.31
  • Revenue Next Year
  • RPRX $5.82
  • SCI $3.42
  • P/E Ratio
  • RPRX $13.52
  • SCI $20.86
  • Revenue Growth
  • RPRX 1.12
  • SCI 2.40
  • 52 Week Low
  • RPRX $24.05
  • SCI $68.51
  • 52 Week High
  • RPRX $34.20
  • SCI $89.37
  • Technical
  • Relative Strength Index (RSI)
  • RPRX 57.01
  • SCI 42.32
  • Support Level
  • RPRX $31.97
  • SCI $74.14
  • Resistance Level
  • RPRX $33.00
  • SCI $77.35
  • Average True Range (ATR)
  • RPRX 0.71
  • SCI 1.95
  • MACD
  • RPRX 0.08
  • SCI -0.29
  • Stochastic Oscillator
  • RPRX 60.08
  • SCI 18.23

About RPRX Royalty Pharma plc

Royalty Pharma PLC is the largest buyer of biopharmaceutical royalties. The firm has a portfolio of royalties that entitles it to payments based on the sales of biopharma products. Royalty Pharma receives royalties on more than 35 commercial products, including AbbVie and Johnson & Johnson's Imbruvica (for chronic lymphocytic leukemia and other blood cancers), Biogen's Tysabri (for relapsing forms of multiple sclerosis), Vertex's cystic fibrosis franchise, and 10 development-stage product candidates.

About SCI Service Corporation International

Service Corp International is a personal services company that provides funeral and cemetery services and products from its locations throughout the United States and Canada. The company segments its operations into funeral service and cemetery business functions. At its funeral service locations, Service Corp. provides all professional services, facilities, vehicles, and merchandise related to funerals and cremations. Cemetery locations provide cemetery property, memorial markers, and graveyard services to customers. Service Corp. derives the majority of its revenue from its funeral services segment. Geographically, the company derives a majority of its revenue from the United States.

Share on Social Networks: